Protagenic Therapeutics, Inc. PTIX · Stock Open Protagenic Therapeutics, Inc. in new tab
Protagenic Therapeutics, Inc. Analysis (PTIX)
Is Protagenic Therapeutics, Inc. a good investment? Protagenic Therapeutics, Inc. (PTIX) is currently trading at 0.8100 USD.
Earnings Schedule: Protagenic Therapeutics, Inc. is expected to release its next earnings report on Nov. 17, 2026. The market consensus estimate for Forward EPS is -0.58.
Investor FAQ
Does Protagenic Therapeutics, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Protagenic Therapeutics, Inc.?
Protagenic Therapeutics, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 17, 2026. The company currently has a trailing EPS of -13.13.
Company Profile
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
| Year | Total Dividends |
|---|---|
| ▸2005 |
0.46 USD
|
| Dec. 5, 2005 | 0.4640 |
| Split Date | Split Ratio to 1 |
|---|---|
| May 3, 2007 | Needs review |
| Dec. 3, 2010 | 1:4 |
| July 27, 2016 | Needs review |
| Jan. 11, 2017 | Needs review |
| March 23, 2023 | 1:4 |
| May 5, 2025 | 0.07 |
Community Discussion